Adenovirus type 4 and type 7 vaccine FDA Approval History
FDA Approved: Yes (First approved March 16, 2011)
Generic name: adenovirus type 4 and type 7 vaccine
Company: Barr Laboratories, Inc.
Treatment for: Infection Prophylaxis
Adenovirus type 4 and type 7 vaccine is an oral vaccine indicated for the prevention of febrile acute respiratory disease caused by adenovirus type 4 and type 7 in military populations.
Adenovirus ProphylaxisDevelopment timeline for adenovirus type 4 and type 7 vaccine
| Date | Article |
|---|---|
| Mar 16, 2011 | Approval FDA Approves the New Adenovirus Vaccine |
| Dec 11, 2008 | Barr's BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDA |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
